Journal of Clinical Endocrinology & Metabolism, Vol 81, 3366-3371, Copyright © 1996 by Endocrine Society

ARTICLES

Bone turnover markers and bone density across the menopausal transition

PR Ebeling, LM Atley, JR Guthrie, HG Burger, L Dennerstein, JL Hopper and JD Wark
Bone and Mineral Service, University of Melbourne, Royal Melbourne Hospital, Victoria, Australia. p.ebeling@medicine.unimelb.edu.au

We measured lunbar spine and femoral neck bone mineral density (BMD); urine markers of bone resorption; serum markers of bone formation; and serum gonadotrophin, estradiol and inhibin concentrations in a population-based cohort of 281 women aged 45-57 yr. Women were classified into pre-, peri-, and postmenopausal groups, depending on menstrual bleeding patterns. Compared with premenopausal women, BMD was lower only in postmenopausal women but not in women currently using hormone replacement therapy (HRT). BMD decreased with age in the perimenopausal group. Compared with premenopausal women, perimenopausal women had 20% greater urine N-telopeptide excretion (P < 0.05) and a doubling of gonadotrophin levels (P < 0.01), whereas serum estradiol and bone formation marker concentrations were no different. Postmenopausal Women had greater levels of bone turnover markers (P < 0.0001), except free deoxypyridinoline and type I procollagen propeptide. Among postmenopausal women, bone resorption markers were lower in those using HRT. Levels of nearly all bone turnover markers were positively related to serum FSH concentrations (P < 0.0001). Overall, the major independent predictors of BMD were age, urine N- telopeptide, serum bone alkaline phosphatase, and serum, FSH, whereas urine free deoxypyridinoline was positively related to BMD in pre- and perimenopausal women. In conclusion, the perimenopause is associated with elevated bone resorption rates and declining BMD, and factors in addition to estrogen deficiency may also contribute to the pathogenesis of postmenopausal osteoporosis.

This article has been cited by other articles:

				F. R. SINGER and D. R. EYRE Using biochemical markers of bone turnover in clinical practice Cleveland Clinic Journal of Medicine, October 1, 2008; 75(10): 739 - 750. [Abstract] [Full Text] [PDF]

				J. S. Finkelstein, S. E. Brockwell, V. Mehta, G. A. Greendale, M. R. Sowers, B. Ettinger, J. C. Lo, J. M. Johnston, J. A. Cauley, M. E. Danielson, et al. Bone Mineral Density Changes during the Menopause Transition in a Multiethnic Cohort of Women J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 861 - 868. [Abstract] [Full Text] [PDF]

				D. S. Perrien, N. S. Akel, P. K. Edwards, A. A. Carver, M. S. Bendre, F. L. Swain, R. A. Skinner, W. R. Hogue, K. M. Nicks, T. M. Pierson, et al. Inhibin A Is an Endocrine Stimulator of Bone Mass and Strength Endocrinology, April 1, 2007; 148(4): 1654 - 1665. [Abstract] [Full Text] [PDF]

				T. Yasui, H. Uemura, J. Tomita, Y. Miyatani, M. Yamada, A. Kuwahara, T. Matsuzaki, M. Maegawa, N. Tsuchiya, M. Yuzurihara, et al. Association of Interleukin-8 with Hot Flashes in Premenopausal, Perimenopausal, and Postmenopausal Women and Bilateral Oophorectomized Women J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4805 - 4808. [Abstract] [Full Text] [PDF]

				J. L. Downs and H. F. Urbanski Neuroendocrine Changes in the Aging Reproductive Axis of Female Rhesus Macaques (Macaca mulatta) Biol Reprod, October 1, 2006; 75(4): 539 - 546. [Abstract] [Full Text] [PDF]

				P. R. Ebeling Inhibin in bone--new tricks for an old dog. J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1669 - 1670. [Full Text] [PDF]

				D. S. Perrien, S. J. Achenbach, S. E. Bledsoe, B. Walser, L. J. Suva, S. Khosla, and D. Gaddy Bone Turnover across the Menopause Transition: Correlations with Inhibins and Follicle-Stimulating Hormone J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1848 - 1854. [Abstract] [Full Text] [PDF]

				M. R. Sowers, M. Jannausch, D. McConnell, R. Little, G. A. Greendale, J. S. Finkelstein, R. M. Neer, J. Johnston, and B. Ettinger Hormone Predictors of Bone Mineral Density Changes during the Menopausal Transition J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1261 - 1267. [Abstract] [Full Text] [PDF]

				M. Gardner, A. Taylor, G. Wei, A. Calcagni Jr, B. Duncan, and A. Milton Clinical Pharmacology of Multiple Doses of Lasofoxifene in Postmenopausal Women J. Clin. Pharmacol., January 1, 2006; 46(1): 52 - 58. [Abstract] [Full Text] [PDF]

				Q. Wang, P. H. F. Nicholson, M. Suuriniemi, A. Lyytikainen, E. Helkala, M. Alen, H. Suominen, and S. Cheng Relationship of Sex Hormones to Bone Geometric Properties and Mineral Density in Early Pubertal Girls J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1698 - 1703. [Abstract] [Full Text] [PDF]

				A Muller, K Jakob, and G E Hein Evaluation of free and peptide bound collagen crosslink excretion in different skeletal diseases Ann Rheum Dis, January 1, 2003; 62(1): 65 - 67. [Abstract] [Full Text] [PDF]

				G. J. E. Oosterhuis, I. Vermes, H. W.B. Michgelsen, J. Schoemaker, and C. B. Lambalk Follicle stimulating hormone measured in unextracted urine throughout the menstrual cycle correlates with age and ovarian reserve Hum. Reprod., March 1, 2002; 17(3): 641 - 646. [Abstract] [Full Text] [PDF]

				H. W. Vesper, L. M. Demers, R. Eastell, P. Garnero, M. Kleerekoper, S. P. Robins, A. K. Srivastava, G. R. Warnick, N. B. Watts, and G. L. Myers Assessment and Recommendations on Factors Contributing to Preanalytical Variability of Urinary Pyridinoline and Deoxypyridinoline Clin. Chem., February 1, 2002; 48(2): 220 - 235. [Abstract] [Full Text] [PDF]

				D. Gaddy-Kurten, J. K. Coker, E. Abe, R. L. Jilka, and S. C. Manolagas Inhibin Suppresses and Activin Stimulates Osteoblastogenesis and Osteoclastogenesis in Murine Bone Marrow Cultures Endocrinology, January 1, 2002; 143(1): 74 - 83. [Abstract] [Full Text] [PDF]

				P. R. Ebeling, J. D. Wark, S. Yeung, C. Poon, N. Salehi, G. C. Nicholson, and M. A. Kotowicz Effects of Calcitriol or Calcium on Bone Mineral Density, Bone Turnover, and Fractures in Men with Primary Osteoporosis: A Two-Year Randomized, Double Blind, Double Placebo Study J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4098 - 4103. [Abstract] [Full Text] [PDF]

				D L. Alekel, A. S. Germain, C. T Peterson, K. B Hanson, J. W Stewart, and T. Toda Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women Am. J. Clinical Nutrition, September 1, 2000; 72(3): 844 - 852. [Abstract] [Full Text] [PDF]

				J. E. Kerstetter, M. E. Mitnick, C. M. Gundberg, D. M. Caseria, A. F. Ellison, T. O. Carpenter, and K. L. Insogna Changes in Bone Turnover in Young Women Consuming Different Levels of Dietary Protein J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 1052 - 1055. [Abstract] [Full Text]

				E. S. Orwoll, N. H. Bell, M. S. Nanes, K. A. Flessland, M. B. Pettinger, N. J. S. Mallinak, and D. F. Cain Collagen N-Telopeptide Excretion in Men: The Effects of Age and Intrasubject Variability J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3930 - 3935. [Abstract] [Full Text]

				D. L. Broyles, R. G. Nielsen, E. M. Bussett, W. D. Lu, I. A. Mizrahi, P. A. Nunnelly, T. A. Ngo, J. Noell, R. H. Christenson, and B. C. Kress Analytical and clinical performance characteristics of Tandem-MP Ostase, a new immunoassay for serum bone alkaline phosphatase Clin. Chem., October 1, 1998; 44(10): 2139 - 2147. [Abstract] [Full Text] [PDF]

				S. Kamel, P. Fardellone, B. Meddah, F. Lorget-Gondelmann, J. L. Sebert, and M. Brazier Response of several markers of bone collagen degradation to calcium supplementation in postmenopausal women with low calcium intake Clin. Chem., July 1, 1998; 44(7): 1437 - 1442. [Abstract] [Full Text] [PDF]

				M. E. Cohen-Solal, F. Boitte, O. Bernard-Poenaru, M. A. Denne, A. M. Graulet, M. Brazier, and M. C. de Vernejoul Increased Bone Resorbing Activity of Peripheral Monocyte Culture Supernatants in Elderly Women J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1687 - 1690. [Abstract] [Full Text]

				I. Gorai, Y. Taguchi, O. Chaki, R. K. M. Nakayama, B. C. Yang, S. Yokota, and H. Minaguchi Serum Soluble Interleukin-6 Receptor and Biochemical Markers of Bone Metabolism Show Significant Variations During the Menstrual Cycle J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 326 - 332. [Abstract] [Full Text]

				E. A. Amama, M. Taga, and H. Minaguchi The Effect of Gonadotropin-Releasing Hormone Agonist on Type I Collagen C-Telopeptide and N-Telopeptide: the Predictive Value of Biochemical Markers of Bone Turnover J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 333 - 338. [Abstract] [Full Text]

				J. D. Clemens, M. V. Herrick, F. R. Singer, and D. R. Eyre Evidence that serum NTx (collagen-type I N-telopeptides) can act as an immunochemical marker of bone resorption Clin. Chem., November 1, 1997; 43(11): 2058 - 2063. [Abstract] [Full Text] [PDF]

				A.-M. Heikkinen, M. Parviainen, L. Niskanen, M. Komulainen, M. T. Tuppurainen, H. Kroger, and S. Saarikoski Biochemical Bone Markers and Bone Mineral Density during Postmenopausal Hormone Replacement Therapy with and without Vitamin D3: A Prospective, Controlled, Randomized Study J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2476 - 2482. [Abstract] [Full Text] [PDF]

				C. J. Rosen, C. H. Chesnut III, and N. J. S. Mallinak The Predictive Value of Biochemical Markers of Bone Turnover for Bone Mineral Density in Early Postmenopausal Women Treated with Hormone Replacement or Calcium Supplementation J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1904 - 1910. [Abstract] [Full Text] [PDF]

				S. Khosla, E. J. Atkinson, L. J. Melton III, and B. L. Riggs Effects of Age and Estrogen Status on Serum Parathyroid Hormone Levels and Biochemical Markers of Bone Turnover in Women: A Population-Based Study J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1522 - 1527. [Abstract] [Full Text] [PDF]

				Bone Turnover Markers May Predict Bone Loss Journal Watch Women's Health, November 1, 1996; 1996(1101): 9 - 9. [Full Text]